Aurinia Pharmaceuticals Inc.
AUPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $32 | $22 | $23 | $1 |
| Dep. & Amort. | $5 | $5 | $5 | $5 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $5 | -$3 | $9 |
| Change in WC | $6 | $6 | -$25 | $22 |
| Other Non-Cash | -$4 | $7 | $1 | -$8 |
| Operating Cash Flow | $44 | $44 | $1 | $30 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$145 | -$92 | -$85 |
| Inv. Sales/Matur. | $0 | $132 | $123 | $124 |
| Other Inv. Act. | -$14 | $0 | $0 | $0 |
| Investing Cash Flow | -$14 | -$13 | $31 | $39 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | -$3 | -$3 | -$3 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$9 | -$43 | -$47 | -$22 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $2 | $0 | $2 |
| Financing Cash Flow | -$10 | -$44 | -$49 | -$23 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $20 | -$13 | -$17 | $46 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53 | $66 | $83 | $37 |
| End Cash | $73 | $53 | $66 | $83 |
| Free Cash Flow | $44 | $44 | $1 | $30 |